Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Recruiting · NCT04526093 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Health Network, Toronto
View the official record on ClinicalTrials.gov →Interventions studied
Medical Cannabis
What this trial is about
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
- Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
- Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
Exclusion criteria
- Concomitant use of illicit drugs
- Concomitant use of recreational cannabis
Where it is running
1 location listed.
- Toronto General Hospital, UHN - Toronto, Ontario, Canada